Pancreatic Cancer

HOUSTON, May 6, 2026 Diakonos Oncology Corp., a clinical-stage biotechnology company focused on next-generation cancer immunotherapies, has announced that...

MEQUON, Wis., May 1, 2026 Vector Science & Therapeutics, Inc. has announced the filing of a provisional patent application...

PALO ALTO, California, May 1, 2026 Sonire Therapeutics Inc. announced the initiation of its first U.S. clinical trial, SUNRISE-II,...

Houston, USA | May 1, 2026 Diakonos Oncology has reported positive Phase 1 clinical data for its investigational DOC1021...

Mountain View, California, USA – April 23, 2026 RenovoRx announced that a pharmacokinetic (PK) and pharmacodynamic (PD) data abstract...

San Diego, California, USA – April 22, 2026 In a significant development in oncology drug innovation, Phanes Therapeutics has...

Hong Kong, April 20, 2026 In a significant breakthrough in oncology immunotherapy, Akeso, Inc. has announced promising Phase II...

OCALA, Fla., April 16, 2026 AIM ImmunoTech Inc. has announced significant progress in its oncology pipeline, entering a pivotal...

TAIPEI, Taiwan, April 13, 2026 AnBogen Therapeutics has announced that its lead investigational therapy Imofinostat (ABT-301) will be featured...

REDWOOD CITY, Calif., April 2, 2026 Revolution Medicines has announced the initiation of patient dosing in its global Phase...